These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33976733)

  • 41. Skp2 expression has different clinicopathological and prognostic implications in lung adenocarcinoma and squamous cell carcinoma.
    Zhong K; Yang F; Han Q; Chen J; Wang J
    Oncol Lett; 2018 Sep; 16(3):2873-2880. PubMed ID: 30127874
    [TBL] [Abstract][Full Text] [Related]  

  • 42. DNASE1L3 as a Novel Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma Based on Data Mining.
    Chen J; Ding J; Huang W; Sun L; Chen J; Liu Y; Zhan Q; Gao G; He X; Qiu G; Long P; Wei L; Lu Z; Sun Y
    Front Genet; 2021; 12():699242. PubMed ID: 34868195
    [TBL] [Abstract][Full Text] [Related]  

  • 43. LncRNA-AC068228.1 Is a Novel Prognostic Biomarker That Promotes Malignant Phenotypes in Lung Adenocarcinoma.
    Jiang X; Chen M; Du J; Bi H; Guo X; Yang C; He X; Jin Z
    Front Oncol; 2022; 12():856655. PubMed ID: 35280807
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overexpression of LncRNA-UCA1 Correlates with Lung Adenocarcinoma Progression and Poor Prognosis.
    Chen L; Cao P; Wu Q; Guo Y; Yang Y; Chen F
    Clin Lab; 2019 Mar; 65(3):. PubMed ID: 30868851
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Construction and validation of a novel prognostic signature of microRNAs in lung adenocarcinoma.
    Li W; Liu S; Su S; Chen Y; Sun G
    PeerJ; 2021; 9():e10470. PubMed ID: 33510968
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Upregulation of glucosamine-phosphate N-acetyltransferase 1 is a promising diagnostic and predictive indicator for poor survival in patients with lung adenocarcinoma.
    Zhu P; Gu S; Huang H; Zhong C; Liu Z; Zhang X; Wang W; Xie S; Wu K; Lu T; Zhou Y
    Oncol Lett; 2021 Jun; 21(6):488. PubMed ID: 33968204
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Decreased Expression of NUSAP1 Predicts Poor Overall Survival in Cervical Cancer.
    Xie Q; Ou-Yang W; Zhang M; Wang H; Yue Q
    J Cancer; 2020; 11(10):2852-2863. PubMed ID: 32226503
    [No Abstract]   [Full Text] [Related]  

  • 48. DNTTIP1 is a Prognostic Biomarker Correlated With Immune Infiltrates in Hepatocellular Carcinoma: A Study Based on The Cancer Genome Atlas Data.
    Zhu C; Tong R; Jiang X; Xiao H; Guan J; Shu J
    Front Genet; 2021; 12():767834. PubMed ID: 35265097
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic biomarker TUBA1C is correlated to immune cell infiltration in the tumor microenvironment of lung adenocarcinoma.
    Bian T; Zheng M; Jiang D; Liu J; Sun H; Li X; Liu L; Zhang J; Liu Y
    Cancer Cell Int; 2021 Mar; 21(1):144. PubMed ID: 33653340
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CCDC68 predicts poor prognosis in patients with colorectal cancer: a study based on TCGA data.
    Zhang W; Xu TT; An ZT; Wei LF; Gu C; Li H; Tian YZ
    J Gastrointest Oncol; 2022 Apr; 13(2):657-671. PubMed ID: 35557589
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HTRA3 Is a Prognostic Biomarker and Associated With Immune Infiltrates in Gastric Cancer.
    Ji C; Sun LS; Xing F; Niu N; Gao HL; Dai JW; Zhou N; Jiang BC
    Front Oncol; 2020; 10():603480. PubMed ID: 33425760
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of TTN Mutations on Immune Microenvironment and Efficacy of Immunotherapy in Lung Adenocarcinoma Patients.
    Wang Z; Wang C; Lin S; Yu X
    Front Oncol; 2021; 11():725292. PubMed ID: 34513703
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
    Hao XL; Tian Z; Han F; Chen JP; Gao LY; Liu JY
    Pathol Res Pract; 2019 Jul; 215(7):152438. PubMed ID: 31126818
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decreased INPP5B expression predicts poor prognosis in lung adenocarcinoma.
    Deng J; Lin X; Li Q; Cai XY; Wu LW; Wang W; Zhang B; Li YL; Hu J; Lin NM
    Cancer Cell Int; 2022 May; 22(1):189. PubMed ID: 35568951
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High Expression of DEPDC1B Predicts Poor Prognosis in Lung Adenocarcinoma.
    Li P; Chen X; Zhou S; Xia X; Wang E; Han R; Zeng D; Fei G; Wang R
    J Inflamm Res; 2022; 15():4171-4184. PubMed ID: 35912402
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
    Xu XL; Gong Y; Zhao DP
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8731-8739. PubMed ID: 30575913
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.
    Wang W; Ren S; Wang Z; Zhang C; Huang J
    Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LncRNA ADAMTS9-AS2 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Lung Adenocarcinoma.
    Lin Z; Huang W; Yi Y; Li D; Xie Z; Li Z; Ye M
    Int J Gen Med; 2021; 14():8541-8555. PubMed ID: 34849000
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of HMMR as a prognostic biomarker for patients with lung adenocarcinoma
    Li Z; Fei H; Lei S; Hao F; Yang L; Li W; Zhang L; Fei R
    PeerJ; 2021; 9():e12624. PubMed ID: 35036134
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overexpression of Family with Sequence Similarity 83, Member A (FAM83A) Predicts Poor Clinical Outcomes in Lung Adenocarcinoma.
    Zhang JT; Lin YC; Xiao BF; Yu BT
    Med Sci Monit; 2019 Jun; 25():4264-4272. PubMed ID: 31175804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.